Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
URI
|
Marc A Bruno |
BUY
Grant, award, or other acquisition
|
Direct | 118 Added 2.82% |
$27,365
$231.91 p/Share
|
Dec 31
2020 |
URI
|
Bobby J Griffin |
BUY
Grant, award, or other acquisition
|
Direct | 80 Added 0.19% |
$18,553
$231.91 p/Share
|
Dec 31
2020 |
URI
|
Terri L. Kelly |
BUY
Grant, award, or other acquisition
|
Direct | 122 Added 2.22% |
$28,293
$231.91 p/Share
|
Dec 31
2020 |
PRTY
|
Norman S Matthews
Director |
BUY
Grant, award, or other acquisition
|
Direct | 9,248 Added 3.39% |
-
|
Dec 31
2020 |
MRNA
|
Stephane Bancel
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.13% |
$1,105,500
$110.55 p/Share
|
Dec 31
2020 |
NEM
|
John Kitlen
VP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 89 Reduced 0.26% |
$5,338
$59.98 p/Share
|
Dec 31
2020 |
U
|
Ruth Ann Keene
SVP, CLO & GC & Corp Sec'y |
BUY
Exercise of conversion of derivative security
|
Direct | 11,000 Added 16.73% |
$40,590
$3.69 p/Share
|
Dec 31
2020 |
ALLK
|
Paul Edward Walker |
SELL
Open market or private sale
|
Indirect | 35,023 Reduced 0.53% |
$4,922,483
$140.55 p/Share
|
Dec 31
2020 |
VTGN
|
H. Ralph Snodgrass
PRES./CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 5.39% |
$2,250
$0.45 p/Share
|
Dec 31
2020 |
VTGN
|
Mark Alan Smith
CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 33.33% |
$2,250
$0.45 p/Share
|
Dec 31
2020 |
VTGN
|
Jerrold Duane Dotson
VP, CFO |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 33.33% |
$2,250
$0.45 p/Share
|
Dec 31
2020 |
VTGN
|
Shawn Singh
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 5,000 Added 12.38% |
$2,250
$0.45 p/Share
|
Dec 31
2020 |
REV
|
E Scott Beattie |
SELL
Open market or private sale
|
Direct | 13,210 Reduced 20.82% |
$160,369
$12.14 p/Share
|
Dec 31
2020 |
BAND
|
David A. Morken
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 39,591 Reduced 97.95% |
$6,192,032
$156.4 p/Share
|
Dec 31
2020 |
BAND
|
David A. Morken
Chairman & CEO |
BUY
Conversion of derivative security
|
Direct | 39,591 Added 49.48% |
-
|
Dec 31
2020 |
CSV
|
James Raymond Schenck
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,156 Added 4.78% |
$36,206
$31.32 p/Share
|
Dec 31
2020 |
CLAR
|
Warren B Kanders
Executive Chairman |
BUY
Bona fide gift
|
Indirect | 1,935 Added 17.83% |
$29,992
$15.5 p/Share
|
Dec 31
2020 |
CLAR
|
Warren B Kanders
Executive Chairman |
SELL
Bona fide gift
|
Direct | 12,258 Reduced 0.32% |
$189,999
$15.5 p/Share
|
Dec 31
2020 |
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 59,843 Reduced 1.16% |
$441,641
$7.38 p/Share
|
Dec 31
2020 |
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 59,843 Reduced 1.16% |
$441,641
$7.38 p/Share
|
Dec 31
2020 |
MORF
|
Omega Fund V, L.P.
Director |
SELL
Open market or private sale
|
Direct | 3,907 Reduced 0.13% |
$133,619
$34.2 p/Share
|
Dec 31
2020 |
LXU
|
Cheryl Maguire
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,988 Reduced 3.79% |
$12,719
$2.55 p/Share
|
Dec 31
2020 |
ELF
|
Tarang Amin
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 200,000 Reduced 2.75% |
$5,102,000
$25.51 p/Share
|
Dec 31
2020 |
SBCF
|
Juliette Kleffel
EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 554 Reduced 3.2% |
$16,315
$29.45 p/Share
|
Dec 31
2020 |
SBCF
|
Charles M Shaffer
Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,411 Reduced 2.77% |
$41,554
$29.45 p/Share
|
Dec 31
2020 |
SBCF
|
Dennis S Hudson Iii
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 3,860 Reduced 2.1% |
$113,677
$29.45 p/Share
|
Dec 31
2020 |
GBDC
|
Lawrence E Golub
Chairman |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$28,080
$14.04 p/Share
|
Dec 31
2020 |
GBDC
|
David Golub
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 2,000 Added 0.1% |
$28,080
$14.04 p/Share
|
Dec 31
2020 |
BFAM
|
David H Lissy |
SELL
Open market or private sale
|
Direct | 4,822 Reduced 2.15% |
$830,156
$172.16 p/Share
|
Dec 31
2020 |
CTRA
|
Jeffrey W Hutton
Sr. Vice President, Marketing |
BUY
Exercise of conversion of derivative security
|
Direct | 25,806 Added 8.64% |
-
|
Dec 31
2020 |
CTRA
|
Jeffrey W Hutton
Sr. Vice President, Marketing |
SELL
Payment of exercise price or tax liability
|
Direct | 10,155 Reduced 3.72% |
$165,323
$16.28 p/Share
|
Dec 31
2020 |
IBKR
|
Thomas Peterffy
Chairman |
SELL
Open market or private sale
|
Direct | 16,200 Reduced 0.17% |
$984,150
$60.75 p/Share
|
Dec 31
2020 |
KFS
|
Joseph Stilwell
Director |
BUY
Open market or private purchase
|
Indirect | 15,000 Added 0.31% |
$70,950
$4.73 p/Share
|
Dec 31
2020 |
AUB
|
Frank Russell Ellett |
BUY
Open market or private purchase
|
Direct | 1,000 Added 8.54% |
$32,820
$32.82 p/Share
|
Dec 31
2020 |
BALY
|
Stephen H Capp
Executive Vice President, CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 16,679 Reduced 5.15% |
$837,786
$50.23 p/Share
|
Dec 31
2020 |
BALY
|
Stephen H Capp
Executive Vice President, CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 36,785 Added 10.2% |
-
|
Dec 31
2020 |
BALY
|
Marc A Crisafulli
EVP Government Relations |
SELL
Payment of exercise price or tax liability
|
Direct | 16,555 Reduced 39.63% |
$831,558
$50.23 p/Share
|
Dec 31
2020 |
BALY
|
Marc A Crisafulli
EVP Government Relations |
BUY
Exercise of conversion of derivative security
|
Direct | 36,512 Added 46.64% |
-
|
Dec 31
2020 |
BALY
|
Craig L Eaton
Senior VP & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct | 4,850 Reduced 3.56% |
$243,615
$50.23 p/Share
|
Dec 31
2020 |
BALY
|
Craig L Eaton
Senior VP & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct | 10,695 Added 7.28% |
-
|
Dec 31
2020 |
BALY
|
George T. Papanier
President |
SELL
Payment of exercise price or tax liability
|
Direct | 18,483 Reduced 5.17% |
$928,401
$50.23 p/Share
|
Dec 31
2020 |
BALY
|
George T. Papanier
President |
BUY
Exercise of conversion of derivative security
|
Direct | 40,764 Added 10.23% |
-
|
Dec 31
2020 |
WAB
|
David L De Ninno
Exec VP, General Counsel, Sec. |
SELL
Payment of exercise price or tax liability
|
Direct | 870 Reduced 1.03% |
$63,266
$72.72 p/Share
|
Dec 31
2020 |
WAB
|
Patrick D Dugan
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 870 Reduced 0.81% |
$63,266
$72.72 p/Share
|
Dec 31
2020 |
WAB
|
John A Mastalerz Jr
SVP Fin, Corp Controller, CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 214 Reduced 1.05% |
$15,562
$72.72 p/Share
|
Dec 31
2020 |
WBHC
|
Jack W Bell
Director |
BUY
Open market or private purchase
|
Direct | 427 Added 0.41% |
$25,086
$58.75 p/Share
|
Dec 31
2020 |
WBHC
|
James Randall Clemons
Director |
BUY
Other acquisition or disposition
|
Direct | 4,648 Added 4.17% |
$72,881
$15.68 p/Share
|
Dec 31
2020 |
WBHC
|
James Randall Clemons
Director |
SELL
Other acquisition or disposition
|
Indirect | 4,648 Reduced 6.96% |
$72,881
$15.68 p/Share
|
Dec 31
2020 |
YUMAQ
|
Willem Mesdag
> 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect | 169,473 Reduced 100.0% |
-
|
Dec 31
2020 |
JUPW
|
Brian John
Former CEO, Director |
SELL
Bona fide gift
|
Direct | 10,000 Reduced 0.33% |
$51,000
$5.1 p/Share
|
Dec 31
2020 |